Decentralized Clinical Trials in Early Drug Development—A Framework Proposal
The COVID-19 pandemic has led to a rethinking of clinical trial design to maintain clinical research activity, with regulatory changes allowing for the wider implementation and development of decentralized design models. Evidence of the feasibility and benefits associated with a remote design comes...
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado em: |
Innovative Healthcare Institute
2024-08-01
|
| coleção: | Journal of Immunotherapy and Precision Oncology |
| Assuntos: | |
| Acesso em linha: | https://jipo.org/doi/pdf/10.36401/JIPO-23-33 |